Aluminum adjuvants: Overview and utilization in vaccine manufacturing (webinar)

Despite the ubiquity of aluminum adjuvants, they often present development, manufacturing, and quality challenges to manufacturers. As more and more manufacturers work toward World Health Organization prequalification, insights from a manufacturing, quality, analytical, and characterization perspective would be of high value.

This PATH-organized webinar features speakers who are experts in the field, and covers:

  • Chemistry and immunobiology of aluminum adjuvants
  • Good manufacturing practices for producing aluminum-based vaccine adjuvants
  • Approaches for modulating immune response quality
  • Advancements in alum+ adjuvants
  • Lessons learned with aluminum adjuvants

Speakers include:

  • Lakshmi Khandke, Sr. Program Advisor, Vaccines, CMC, Center for Vaccine Innovation and Access, PATH
  • Harm HogenEsch, Professor of Immunology, Purdue University
  • Laurent Duroux, Lead Scientist, R&D, Vaccine Adjuvant Systems, CRODA Pharma
  • Rajesh Gupta, Principal Consultant, Biologics Quality & Regulatory Consultants LLC
  • Robert Sitrin, Senior Scientist, Center for Vaccine Innovation and Access, PATH
  • Christopher Fox, Senior Vice President of Formulations, Access to Advanced Health Institute
  • Derek O'Hagan, Senior Advisor, Vaccines R&D, GSK

Corporate author(s): PATH, Purdue University, CRODA Pharma, Biologics Quality & Regulatory Consultants LLC, Access to Advanced Health Institute, GSK

Publication date: September 2024

Available materials

  1. English

    1. Webinar slides: Part 1 8.3 MB PPTX
    2. Webinar slides: Part 2 29.9 MB PPTX
    3. Webinar slides: Part 3 20.9 MB PPTX

  2. English

    1. Webinar: Part 1
    2. Webinar: Part 2